The ADNO Conference, held on Monday, December 2nd in Paris, went very well. Although it began with some minor technical problems, it did not prevent me from speaking to an attentive audience of professionals. I described how Mirko Beljanski, while working at the Pasteur Institute, first discovered a synergy of action between the chemotherapy drug, Lomustine and his plant extracts. This synergy of action was later observed by researchers at Columbia University with another chemotherapy drug, Docetaxel and most recently, this synergy was confirmed with two more drugs, Gemcitabine and Carboplatin at the University of Kansas Medical Center.

What is remarkable is that each of these chemotherapy drugs are molecules with different structures and therefore have different effects from each other – sometimes even antagonistic in nature. But when used in combination with the extracts, the potential of each drug to inhibit the replication of cancer cells is significantly enhanced.  And this is the case, whether the cancer is a lymphoma, as seen in Beljanski’s experiments at the Pasteur Institute, a prostate cancer as seen at Columbia University, or an ovarian and pancreatic cancer as seen at the University of Kansas Medical Center.

The similarity observed within this “mini meta-analysis”, despite the disparity of molecular structures of all these chemotherapeutic agents and their disparate modes of action, is explained by the fact that they all contribute to further destabilization of the cancer cell DNA. And it is precisely the destabilized DNA that is targeted by the Beljanski extracts. Once bound to destabilized DNA, the compounds in the extracts prevent DNA duplication.

The principle of gradual and cumulative destabilization of DNA by exogenous agents is now at the heart of scientific explanations behind the emergence of environmental medicine.

This weekend, Dr. Mirko Beljanski was finally recognized by his peers in France and hailed as a pioneer far too ahead of his time to be understood by his contemporaries.

My sincere thanks to Dr. Dominique Rueff, and the ADNO for sponsoring this event and allowing me to be a part of it.